PW Medtech GroupFRA:PWE 82 FCF Margin % is 19.87% as of Dec. 2025, which is 28% above its 10-year median of 15.50. GuruFocus rates FRA:PWE with a GF Score™ of 82/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, PW Medtech Group ranks better than 86.38% on this metric.
The historical rank and industry rank for PW Medtech Group's FCF Margin % or its related term are showing as below:
FRA:PWE'
s FCF Margin % Range Over the Past 10 Years
Min: -26.6 Med: 15.5 Max: 38.63
Current: 16.48
During the past 13 years, the highest FCF Margin % of PW Medtech Group was 38.63%. The lowest was -26.60%. And the median was 15.50%.
FRA:PWE's FCF Margin % is ranked better than 86.38% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:PWE: 16.48
PW Medtech Group FCF Margin % Related Terms
PW Medtech Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (FRA:PWE) has a FCF Margin % of 19.87% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PW Medtech Group and its competitors. This is 28% above median its historical median of 15.50. According to the industry distribution chart, PW Medtech Group ranks #111 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 13.6%.
Is PW Medtech Group's FCF Margin % too high?
PW Medtech Group's current FCF Margin % of 19.87% is 28% above median its 10-year median of 15.50. Based on the distribution chart, PW Medtech Group ranks #111 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #111 out of 815 companies for FCF Margin %. This places PW Medtech Group in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PW Medtech Group and its competitors. PW Medtech Group's current FCF Margin % is 19.87%, which is 28% above median its own 10-year median of 15.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current FCF Margin % of 19.87%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 15.4% below its estimated fair value. The current FCF Margin % is 19.87%, which is 28% above median its 10-year median of 15.50. PW Medtech Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current FCF Margin % is 19.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 15.4% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
FCF Margin %: 19.87% (28% above median its 10-year median of 15.50)
GF Value™: €0.13 vs. price of €0.11 (15.4% below fair value)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
82GF Score
Get the complete analysis for FRA:PWE
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
